AcuCort wins renewed FDA small business waiver, avoiding SEK 16 million NDA filing fee

Reuters2026/07/27 06:10

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

AcuCort secured a renewed FDA Small Business Waiver, removing the user fee for its planned NDA filing.
The waiver avoids an application fee of about SEK 16 million, lowering near-term regulatory costs ahead of a targeted 2026 submission.
FDA previously agreed no additional studies are required to file the NDA, supporting the company’s stated timeline.
NDA review typically takes about 12 months, setting up a potential U.S. regulatory decision roughly a year after filing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief via Cision (Ref. ID: 202607270210BITN____UKPR__SV_20260726-BIT-1859-0) on July 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AcuCort wins renewed FDA small business waiver, avoiding SEK 16 million NDA filing fee

You may also like

Crypto prices